Cardinal Health Launches New Latex-Free Flexal Feel Nitrile Exam Gloves
Cardinal Health announces the launch of Flexal® Feel Nitrile Exam Gloves, the lightest-weight glove in its exam glove portfolio.
Flexal® Feel Nitrile Exam Gloves offer the comfort and protection of a nitrile glove with the tactile sensitivity of a latex one. Their form-fitting, lighter feel promotes natural hand movement.
A powder-free addition to Cardinal Healths exam glove portfolio, Flexal® Feel Nitrile Exam Gloves also feature a textured fingertip that provides enhanced grip over traditional nitrile gloves without compromising reliability or durability.
"We continue to innovate our product portfolio to provide solutions that will help our customers provide quality care, and were pleased to offer this alternative in Flexal® Feel Nitrile Exam Gloves," says Mike Duffy, president of Medical Consumables.
Flexal® Feel Nitrile Exam Gloves also provide an environmentally friendly alternative to latex and nitrile gloves currently available in the market. As the lightest weight nitrile glove in the Cardinal Health exam glove portfolio, the gloves are packaged 300 per box (250 per box for size XL), helping reduce waste by packaging more gloves per box than most other exam gloves. The box dimensions remain the same and fit standard glove box holders.Â
The newest addition to the Cardinal Healths exam glove portfolio, Flexal Feel Nitrile Exam Gloves complement the Esteem®, Flexal® , Flexam®, and InstaGard® product lines and the companys Protexis family of market-leading surgical gloves.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
